Samantha Colledge-Frisby, Sophie Ottaviano, Paige Webb, Jason Grebely, Alice Wheeler, Evan B Cunningham, Behzad Hajarizadeh, Janni Leung, Amy Peacock, Peter Vickerman, Michael Farrell, Greg Dore, Matthew Hickman, Louisa Degenhardt
BACKGROUND: Harm reduction and treatment programmes are essential for reducing harms for people who inject drugs (PWID). We aimed to update estimates from a 2017 review of global coverage of needle and syringe exchange programmes (NSPs), opioid agonist treatment (OAT), and other harm reduction services that target PWID (eg, take-home naloxone [THN] programmes, supervised consumption facilities, and drug checking services). METHODS: We did a systematic review of available evidence from peer-reviewed and grey literature databases for studies published between Jan 1, 2017, and May 31, 2022...
March 27, 2023: Lancet Global Health